Literature DB >> 22482939

Mitochondrial diseases.

Anthony H V Schapira1.   

Abstract

Mitochondria have a crucial role in cellular bioenergetics and apoptosis, and thus are important to support cell function and in determination of cell death pathways. Inherited mitochondrial diseases can be caused by mutations of mitochondrial DNA or of nuclear genes that encode mitochondrial proteins. Although many mitochondrial disorders are multisystemic, some are tissue specific--eg, optic neuropathy, sensorineural deafness, and type 2 diabetes mellitus. In the past few years, several disorders have been associated with mutations of nuclear genes responsible for mitochondrial DNA maintenance and function, and the potential contribution of mitochondrial abnormalities to progressive neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease has been recognised. The process of mitochondrial fission-fusion has become a focus of attention in human disease. Importantly, the mitochondrion is now a target for therapeutic interventions that encompass small molecules, transcriptional regulation, and genetic manipulation, offering opportunities to treat a diverse range of diseases.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482939     DOI: 10.1016/S0140-6736(11)61305-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  158 in total

1.  Quo vadis: the re-definition of "inborn metabolic diseases".

Authors:  Eva Morava; Shamima Rahman; Verena Peters; Matthias R Baumgartner; Marc Patterson; Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2015-09-29       Impact factor: 4.982

2.  The efficiency of the translesion synthesis across abasic sites by mitochondrial DNA polymerase is low in mitochondria of 3T3 cells.

Authors:  Natalya Kozhukhar; Domenico Spadafora; Rafik Fayzulin; Inna N Shokolenko; Mikhail Alexeyev
Journal:  Mitochondrial DNA A DNA Mapp Seq Anal       Date:  2015-10-16       Impact factor: 1.514

3.  Mitochondrial swelling and restorable fragmentation stimulated by femtosecond laser.

Authors:  Fan Shi; Hao He; Yintao Wang; Dayong Liu; Minglie Hu; Chingyue Wang
Journal:  Biomed Opt Express       Date:  2015-10-23       Impact factor: 3.732

4.  A transcriptional signature of hub connectivity in the mouse connectome.

Authors:  Ben D Fulcher; Alex Fornito
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-15       Impact factor: 11.205

5.  Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease.

Authors:  S Ylönen; P Ylikotila; A Siitonen; S Finnilä; J Autere; K Majamaa
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

Review 6.  Mitophagy in hematopoietic stem cells: the case for exploration.

Authors:  Aashish Joshi; Mondira Kundu
Journal:  Autophagy       Date:  2013-10-11       Impact factor: 16.016

7.  Novel mitochondrial C15620A variant may modulate the phenotype of mitochondrial G11778A mutation in a Chinese family with Leigh syndrome.

Authors:  Kunqian Ji; Jinfan Zheng; Baoying Sun; Fuchen Liu; Jingli Shan; Duoling Li; Yue-Bei Luo; Yuying Zhao; Chuanzhu Yan
Journal:  Neuromolecular Med       Date:  2013-09-24       Impact factor: 3.843

Review 8.  Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.

Authors:  Daisuke Ino; Masamitsu Iino
Journal:  Cell Mol Life Sci       Date:  2016-09-16       Impact factor: 9.261

9.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

10.  GLTSCR2/PICT1 links mitochondrial stress and Myc signaling.

Authors:  John C Yoon; Alvin J Y Ling; Meltem Isik; Dong-Young Donna Lee; Michael J Steinbaugh; Laura M Sack; Abigail N Boduch; T Keith Blackwell; David A Sinclair; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.